Postmenopausal bleeding (PMB) is any vaginal bleeding that occurs at least 12 months after a woman’s last menstrual period, marking menopause1 . Although bleeding after menopause is uncommon, it affects about 10% of women over 55 and can signal a range of conditions from benign to serious2 3. Early recognition and evaluation of PMB are crucial because it may indicate endometrial cancer or other gynecological issues that require prompt treatment1 4.
Common Causes of Postmenopausal Bleeding
Postmenopausal bleeding arises from various causes, most of which are benign but some carry a risk of malignancy. Understanding these causes helps guide appropriate diagnosis and management.
Vaginal Atrophy
Vaginal atrophy, also known as atrophic vaginitis, occurs due to decreased estrogen levels after menopause. This leads to thinning, drying, and inflammation of the vaginal walls, making them fragile and prone to bleeding, especially after intercourse2 5. Vaginal atrophy is the most common cause of PMB, accounting for about 60% of cases6 . Symptoms often include light spotting or bleeding and vaginal discomfort.
Endometrial Atrophy
Endometrial atrophy refers to thinning of the uterine lining (endometrium) after menopause due to low hormone levels. The thin endometrium becomes fragile and can bleed with minimal trauma1 7. Histopathological studies show atrophic endometrium as a major benign cause of PMB, present in approximately 14% to 60% of cases depending on the population studied1 87. Bleeding from atrophic endometrium is usually light and intermittent.
Polyps and Fibroids
Uterine polyps are benign growths of the endometrial tissue that can cause irregular bleeding after menopause. Polyps account for about 20% to 30% of PMB cases9 2. Fibroids (leiomyomas) are benign smooth muscle tumors of the uterus that may persist or occasionally grow after menopause, especially in obese women due to peripheral estrogen production9 6. Both polyps and fibroids can cause spotting or heavier bleeding.
Endometrial Hyperplasia
Endometrial hyperplasia is the abnormal thickening of the uterine lining, often due to excess estrogen unopposed by progesterone. This condition can cause irregular bleeding and may progress to endometrial cancer if untreated9 10. Non-atypical hyperplasia is usually benign and treated with progestins, while atypical hyperplasia requires closer monitoring or surgery9 .
Endometrial Cancer
Endometrial cancer is a serious but less common cause of PMB, found in about 10% to 12% of women presenting with bleeding after menopause1 82. It is the most common gynecologic malignancy in postmenopausal women, and over 90% of women with endometrial cancer experience vaginal bleeding11 . Early detection through evaluation of PMB significantly improves prognosis1 4.
When To See a Doctor
Any vaginal bleeding occurring more than 12 months after the last menstrual period should prompt immediate medical evaluation2 5. This includes light spotting, pink or brown discharge, or heavier bleeding. Women should also seek care if bleeding occurs after starting or stopping hormone replacement therapy (HRT) 3.
Risk factors that increase the likelihood of serious causes like endometrial cancer include obesity, diabetes, late menopause, smoking, and use of tamoxifen or unopposed estrogen5 10. Prompt consultation with a healthcare provider ensures timely diagnosis and treatment.
“Bleeding after menopause is not normal. Although bleeding may be caused by your activity level, or by an infection or thinning of the vaginal or vulvar skin, it also could be a symptom of something more serious.”
— Katie Casper, M.D., Mayo Clinic Health System5
How Postmenopausal Bleeding Is Diagnosed
A thorough evaluation is essential to identify the cause of PMB and rule out malignancy. Diagnosis typically involves a combination of clinical examination, imaging, and tissue sampling.
Physical Exam
The initial step includes a pelvic exam to inspect the vagina, cervix, and uterus for visible sources of bleeding or lesions. The doctor may use a speculum to visualize the cervix and vagina and palpate the uterus to assess size and tenderness12 13. If no obvious source is found, bleeding from the urinary or gastrointestinal tract may be considered.
Endometrial Biopsy
Endometrial biopsy is the gold standard for diagnosing the cause of PMB. It involves obtaining a small tissue sample from the uterine lining for histopathological examination1 9. This procedure can be done in the office using a thin catheter or during hysteroscopy or dilation and curettage (D&C) if needed12 10. Biopsy helps detect hyperplasia, malignancy, or benign changes.
Transvaginal Ultrasound
Transvaginal ultrasound uses a probe inserted into the vagina to visualize the uterus and measure endometrial thickness9 7. An endometrial thickness of less than 4 mm generally suggests a low risk of cancer, while thicker linings warrant further investigation6 . Ultrasound can also detect polyps, fibroids, or other structural abnormalities.
Laboratory Tests
Additional tests may include blood work such as complete blood count (CBC) to check for anemia, thyroid function tests, and coagulation studies if bleeding disorders are suspected6 . Vaginal cultures may be done if infection is a concern. Pap smears are not diagnostic for PMB but can help identify cervical pathology6 .
Postmenopausal Bleeding Treatments
Treatment depends on the underlying cause of bleeding and patient factors such as age, comorbidities, and preferences.
- Vaginal and Endometrial Atrophy: Topical estrogen therapy is effective in restoring vaginal and uterine lining health, reducing bleeding and symptoms2 5. Nonhormonal lubricants and moisturizers may also help vaginal dryness6 .
- Polyps and Fibroids: Surgical removal, often via hysteroscopic polypectomy or myomectomy, is the preferred treatment for symptomatic lesions9 6. Surgery allows for tissue diagnosis and symptom relief.
- Endometrial Hyperplasia: Progestin therapy is used to reverse benign hyperplasia by inducing shedding of the endometrial lining9 10. Curettage may be performed to remove thickened tissue.
- Infections: Antibiotics treat infections causing bleeding, guided by culture results6 .
- Hormone Therapy-Related Bleeding: Adjusting or discontinuing hormone replacement therapy may resolve bleeding2 .
Treatment for Endometrial Cancer
Endometrial cancer requires surgical management, typically hysterectomy with removal of the uterus and cervix. Depending on the stage, ovaries and fallopian tubes may also be removed10 . Additional treatments such as chemotherapy or radiation may be necessary based on tumor spread6 . Early diagnosis through evaluation of PMB greatly improves survival outcomes1 4.
Can Postmenopausal Bleeding Be Prevented?
Preventive strategies focus on reducing modifiable risk factors for endometrial pathology. Maintaining a healthy weight, managing diabetes, and avoiding unopposed estrogen therapy can lower the risk of hyperplasia and cancer1 6. Awareness initiatives encourage women to seek prompt medical attention for any bleeding after menopause, improving early detection and outcomes1 .
Surgical removal of polyps in high-risk women and appropriate management of hormone therapy also contribute to prevention9 . Routine screening for endometrial cancer in asymptomatic women is not recommended, but early evaluation of bleeding is essential1 .
Summary and Key Takeaways
- Postmenopausal bleeding is any vaginal bleeding occurring 12 months or more after the last menstrual period and always requires medical evaluation1 2.
- The most common causes are benign, including vaginal and endometrial atrophy, polyps, fibroids, and endometrial hyperplasia1 9.
- About 10% to 12% of PMB cases are due to endometrial cancer, making early diagnosis critical1 8.
- Diagnosis involves pelvic exam, transvaginal ultrasound, and endometrial biopsy, which is the gold standard for detecting malignancy1 97.
- Treatment depends on the cause and ranges from topical estrogen and progestins to surgical removal of polyps or hysterectomy for cancer9 10.
- Preventive measures include managing risk factors like obesity and hormone therapy and educating women to report any postmenopausal bleeding promptly1 6.
